Education
About Us
Working with TipRanks
Follow Us
Bed Bath & Beyond (BBBY)
NYSE:BBBY
Top Page
Bed Bath & Beyond
(NYSE:BBBY)
Select Model
Select Model
Rating:46Neutral
Price Target:
$9.00
▼(-5.46% Downside)
The overall stock score reflects significant financial challenges, with declining revenues and persistent losses being the most impactful factors. While there are some positive technical indicators and strategic improvements noted in the earnings call, the negative valuation metrics and ongoing financial difficulties weigh heavily on the stock's attractiveness.
Positive Factors
Strategic Partnerships
Strategic partnerships can enhance market reach and product offerings, providing a foundation for future revenue growth and competitive advantage.
Cost Efficiency
Improved cost efficiency can lead to better margins and profitability, allowing the company to reinvest in growth initiatives and strengthen its financial position.
Margin Improvement
Sustained margin improvement indicates operational efficiency and pricing power, which are crucial for long-term profitability and financial health.
Negative Factors
Revenue Decline
A significant year-over-year revenue decline suggests challenges in market demand or competitive pressures, impacting long-term growth prospects.
Negative Cash Flows
Persistent negative cash flows can strain liquidity and necessitate external financing, potentially affecting the company's financial stability and growth capacity.
Asset Base Contraction
A shrinking asset base limits the company's ability to invest in growth opportunities, potentially hindering future expansion and competitiveness.
Bed Bath & Beyond (BBBY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$563.15M
Dividend YieldN/A
Average Volume (3M)2.49M
Price to Earnings (P/E)―
Beta (1Y)2.59
Revenue Growth-26.63%
EPS Growth45.71%
CountryUS
Employees32,000
SectorConsumer Cyclical
Sector Strength84
IndustrySpecialty Retail
Share Statistics
EPS (TTM)-0.34
Shares Outstanding57,405,975
10 Day Avg. Volume2,558,775
30 Day Avg. Volume2,492,316
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.49
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit1.05
Enterprise Value/Ebitda-1.58
Forecast
1Y Price Target
$11.67Price Target Upside22.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Bed Bath & Beyond Business Overview & Revenue Model
Company DescriptionBed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products. As of February 26, 2022, the company had 953 stores, which included 771 Bed Bath & Beyond stores in 50 states, the District of Columbia, Puerto Rico, and Canada; 130 buybuy BABY stores in 37 states and Canada; and 52 stores in 6 states under the names Harmon, Harmon Face Values or Face Values. It also offers products through various Websites and applications comprising bedbathandbeyond.com, bedbathandbeyond.ca, harmondiscount.com, facevalues.com, buybuybaby.com, buybuybaby.ca, and decorist.com. In addition, the company operates Decorist, an online interior design platform that provides personalized home design services. Bed Bath & Beyond Inc. was incorporated in 1971 and is headquartered in Union, New Jersey.
How the Company Makes MoneyBeyond Inc generates revenue through a multi-faceted business model. Key revenue streams include subscription fees from users accessing its telehealth services and premium features of its mobile applications. The company also earns money through partnerships with healthcare providers and insurance companies, who utilize Beyond's technology to enhance patient care and streamline operations. Additionally, Beyond Inc may generate income from data analytics services, offering insights to healthcare organizations based on aggregated user data. Significant collaborations with health tech firms and wellness brands further bolster its earnings, enabling cross-promotional opportunities and expanded market reach.
Bed Bath & Beyond Earnings Call Summary
Earnings Call Date:Jul 28, 2025
(Q2-2025)
| % Change Since: |
Next Earnings Date:Oct 23, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with strong short-term improvements in revenue from the first quarter, margin gains, and cost efficiencies. However, the company still faces challenges with year-over-year revenue decline and ongoing losses in adjusted EBITDA and GAAP EPS. The strategic moves and partnerships show promise for future growth.Q2-2025 Updates
Positive Updates
Revenue Increase in Q2
Revenue for the quarter was $282 million, marking a 22% increase from Q1 2025 due to a seasonal AOV improvement of $25 and an 8% increase in orders delivered.
Margin Improvement
Gross margin improved by 360 basis points to 23.7% compared to the same period last year, driven by a focus on outdoor categories.
Cost Efficiency Achievements
Sales and marketing expenses decreased by $28 million year-over-year, improving efficiency by 320 basis points. G&A and tech expenses also decreased by $9 million.
Improved Cash Flow
Cash flow for the quarter was materially better than Q1, marking the best performing cash flow quarter in several years.
Strategic Partnerships
Entered a long-term licensing agreement in Canada with an upfront payment of $5 million, and a strategic investment in retail partner Kirkland's, known as The Brand House Collective.
Negative Updates
Revenue Decline Year-over-Year
Revenue declined 29% year-over-year in the second quarter.
Adjusted EBITDA Loss
Adjusted EBITDA came in at a loss of $8 million, though this was a 78% improvement versus the second quarter of 2024.
GAAP EPS Loss
Reported GAAP EPS was a loss of $0.34 per share, with an adjusted diluted loss of $0.22.
Company Guidance
During the Q2 2025 earnings call for Beyond Inc., management provided detailed guidance and updates on several key metrics. The company reported revenue of $282 million for the quarter, marking a 22% increase from Q1 2025, though it was down 29% year-over-year. The gross margin improved to 23.7%, a 360 basis point increase from the previous year, despite being slightly below the anticipated range. The average order value (AOV) rose by $25, driven by effective promotional strategies. Selling and marketing expenses decreased by $28 million year-over-year, improving efficiency by 320 basis points. The company also achieved a significant reduction in G&A and tech expenses by $9 million, aligning with their goal to cut fixed costs annually by $80 million. Adjusted EBITDA showed a loss of $8 million, a 78% improvement year-over-year, and cash flow for the quarter was positive, attributed to better inventory management and SG&A control. Going forward, the company remains focused on maintaining its margin guardrails, improving marketing efficiency, and enhancing customer experience through strategic site and assortment improvements.Bed Bath & Beyond Financial Statement Overview
Summary
Beyond Inc faces significant financial challenges, with declining revenues and persistent losses. The balance sheet remains stable with low leverage, but the shrinking asset base and negative cash flows highlight concerns about liquidity and operational sustainability.Income Statement
Beyond Inc has experienced a consistent decline in revenue, with a notable decrease in total revenue from $2.75 billion in 2021 to $1.13 billion in TTM 2025. Gross profit and net income margins are negative, indicating operational and financial challenges, as the company has not been profitable over the years. The TTM EBIT and EBITDA margins are also negative, reflecting ongoing operational inefficiencies.30
Negative
Balance Sheet
The balance sheet shows a relatively low debt-to-equity ratio, indicating conservative leverage practices. However, the consistent decline in total assets and stockholders' equity over the years suggests a contraction in the company's asset base, potentially limiting growth opportunities. The equity ratio remains healthy, showing a solid capital structure despite the challenges.45
Neutral
Cash Flow
The cash flow statement reveals negative operating and free cash flows, indicating cash outflows from core operations. This could be a significant concern for sustaining operations without external financing. The free cash flow to net income ratio is negative, underscoring the company's struggle to generate cash from its earnings.25
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.13B | 1.39B | 1.56B | 5.34B | 7.87B | 9.23B |
| Gross Profit | 260.74M | 290.16M | 366.03M | 1.21B | 2.48B | 3.12B |
| EBITDA | -173.18M | -236.85M | -244.91M | -2.99B | -114.33M | 81.06M |
| Net Income | -201.51M | -258.80M | -307.84M | -3.50B | -559.62M | -150.77M |
Balance Sheet | ||||||
| Total Assets | 358.07M | 401.95M | 635.82M | 2.23B | 5.13B | 6.46B |
| Cash, Cash Equivalents and Short-Term Investments | 120.55M | 159.17M | 302.61M | 65.85M | 439.50M | 1.35B |
| Total Debt | 25.37M | 32.66M | 3.75M | 3.25B | 3.03B | 3.06B |
| Total Liabilities | 226.87M | 239.22M | 276.69M | 5.03B | 4.96B | 5.18B |
| Stockholders Equity | 130.87M | 162.73M | 359.13M | -2.80B | 174.15M | 1.28B |
Cash Flow | ||||||
| Free Cash Flow | -113.35M | -194.66M | -63.58M | -1.32B | -336.33M | 85.03M |
| Operating Cash Flow | -98.89M | -174.30M | -18.59M | -990.98M | 17.85M | 268.11M |
| Investing Cash Flow | 8.05M | 24.93M | -44.63M | -298.74M | -349.18M | 737.88M |
| Financing Cash Flow | 52.04M | 32.72M | -5.49M | 967.03M | -606.02M | -632.30M |
Bed Bath & Beyond Technical Analysis
Positive
9.52
Price Trends
9.26
Positive
7.69
Positive
6.81
Positive
Market Momentum
0.25
Positive
49.57
Neutral
19.19
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BBBY, the sentiment is Positive. The current price of 9.52 is below the 20-day moving average (MA) of 9.67, above the 50-day MA of 9.26, and above the 200-day MA of 6.81, indicating a neutral trend. The MACD of 0.25 indicates Positive momentum. The RSI at 49.57 is Neutral, neither overbought nor oversold. The STOCH value of 19.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BBBY.
Bed Bath & Beyond Risk Analysis
Bed Bath & Beyond disclosed 42 risk factors in its most recent earnings report. Bed Bath & Beyond reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Bed Bath & Beyond Peers Comparison
Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | 15.97B | 108.61 | 38.76% | ― | 9.04% | -56.79% | |
63 Neutral | 1.42B | -11.39 | -114.16% | ― | -13.22% | 0.00% | |
56 Neutral | 986.51M | -33.88 | -9.14% | ― | -2.83% | 97.94% | |
51 Neutral | 146.01M | -4.99 | -31.79% | ― | -3.08% | 14.42% | |
46 Neutral | $563.15M | ― | -105.72% | ― | -26.63% | 45.71% | |
40 Underperform | 253.38M | -0.92 | -367.24% | ― | -9.95% | 39.66% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
* Consumer Cyclical Sector Average
Performance Comparison
BBBY
Bed Bath & Beyond
9.52
-0.43
-4.32%
JMIA
Jumia Technologies AG
11.62
7.11
157.65%
CHWY
Chewy
38.49
8.62
28.86%
CHPT
ChargePoint Holdings
10.85
-16.15
-59.81%
BARK
BARK Inc Class A
0.86
-0.75
-46.58%
WOOF
Petco Health and Wellness Company
3.52
-0.90
-20.36%
Bed Bath & Beyond Corporate Events
Executive/Board ChangesShareholder Meetings
Beyond Inc Approves Amendment to Equity Incentive Plan
Neutral
May 21, 2025
Beyond, Inc. held its annual meeting of stockholders on May 15, 2025, where several key proposals were voted upon. Notably, the stockholders approved an amendment to the company’s 2005 Equity Incentive Plan, allowing increased award limits for Executive Chairman Marcus A. Lemonis. This decision, made after the Board’s recommendation, reflects the company’s strategic focus on executive compensation and governance, potentially impacting its leadership dynamics and stakeholder relations.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.